-
-
Call more information
660-596-2224 -
Anesthesia & Analgesia: May 2016 – Volume 122 – Issue 5 – p 1696–1703 AUTHORS: Elkassabany, Nabil M. MD, MSCE et al BACKGROUND: Adductor canal block (ACB) has emerged as an appealing alternative to femoral nerve block (FNB) that produces a predominantly sensory nerve block by anesthetizing the saphenous nerve. Studies have shown greater quadriceps […]
Read MoreAnesthesia & Analgesia: May 2016 – Volume 122 – Issue 5 – p 1594–1602 AUTHORS: Bihorac, Azra MD, MS et al BACKGROUND: Stress-induced cardiomyopathy (SCM) after subarachnoid hemorrhage (SAH) includes predominant apical or basal regional left ventricular dysfunction (RLVD) with concomitant changes in electrocardiogram or increase in cardiac enzymes. We hypothesized that difference in outcome […]
Read MoreAnesthesia & Analgesia: May 2016 – Volume 122 – Issue 5 – p 1516–1523 AUTHORS: Lim, Grace MD et al BACKGROUND: There are many teaching methods for epidural anesthesia skill acquisition. Previous work suggests that there is no difference in skill acquisition whether novice learners engage in low-fidelity (LF) versus high-fidelity haptic simulation for epidural […]
Read MoreThe US Food and Drug Administration (FDA) today announced new class-wide safety labeling changes for immediate-release (IR) opioid pain medications, which make up about 90% of all opioid prescriptions. The new labels include a new boxed warning about the risks for misuse, abuse, addiction, overdose and death. In addition, as they did in 2013 with […]
Read MoreRepeated subcutaneous injections of botulinum toxin A (Botox, Allergan) provides analgesic relief to patients with neuropathic pain, a new randomized controlled trial has shown. The study showed that two series of injections were safe and effective for treating peripheral neuropathic pain, especially in a subgroup of patients with allodynia. This research is important because neuropathic […]
Read More